Northern Trust Corp purchased a new position in shares of Inspire Medical Systems (NASDAQ:INSP) in the 2nd quarter, HoldingsChannel.com reports. The fund purchased 94,571 shares of the company’s stock, valued at approximately $3,373,000.
A number of other large investors have also recently added to or reduced their stakes in the stock. Orbimed Advisors LLC acquired a new stake in Inspire Medical Systems during the 2nd quarter worth approximately $87,161,000. Millennium Management LLC acquired a new stake in Inspire Medical Systems during the 2nd quarter worth approximately $26,752,000. BlackRock Inc. acquired a new stake in Inspire Medical Systems during the 2nd quarter worth approximately $19,624,000. FMR LLC acquired a new stake in Inspire Medical Systems during the 2nd quarter worth approximately $11,340,000. Finally, Federated Investors Inc. PA acquired a new stake in Inspire Medical Systems during the 2nd quarter worth approximately $10,949,000.
Shares of NASDAQ INSP opened at $43.64 on Monday. Inspire Medical Systems has a fifty-two week low of $22.50 and a fifty-two week high of $57.87.
In other Inspire Medical Systems news, CEO Timothy P. Herbert sold 15,000 shares of Inspire Medical Systems stock in a transaction on Tuesday, November 20th. The stock was sold at an average price of $39.89, for a total value of $598,350.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Randy Ban sold 10,000 shares of the business’s stock in a transaction on Tuesday, November 20th. The stock was sold at an average price of $40.37, for a total value of $403,700.00. The disclosure for this sale can be found here.
Several analysts recently weighed in on INSP shares. Zacks Investment Research cut Inspire Medical Systems from a “hold” rating to a “sell” rating in a report on Wednesday, November 21st. Leerink Swann began coverage on Inspire Medical Systems in a report on Monday, October 29th. They issued an “outperform” rating and a $57.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $40.86.
WARNING: This piece was originally reported by WKRB News and is the sole property of of WKRB News. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of international copyright & trademark legislation. The legal version of this piece can be viewed at https://www.wkrb13.com/2018/11/26/northern-trust-corp-purchases-new-holdings-in-inspire-medical-systems-insp.html.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Featured Article: No Load Funds
Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Inspire Medical Systems (NASDAQ:INSP).
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.